PRNewswire
CONCEPT MEDICAL ANNONCE LES DONNÉES PRÉLIMINAIRES À 3 ANS DE SIRONA AU SYMPOSIUM CHARING CROSS 2026LONDRES, 28 avril 2026 /PRNewswire/ — Concept Medical Inc., a annoncé aujourd’hui la présentation des données préliminaires issues du suivi… Read more »- Concept Medical anuncia datos preliminares de 3 años sobre Sirona en el Simposio de Charing Cross 2026LONDRES, 28 de abril de 2026 /PRNewswire/ — Concept Medical Inc., anunció hoy la presentación de datos preliminares de seguimiento… Read more »
Apertura Gene Therapy and Scientists from the Broad Institute to Share Data on TfR1 CapX™, a Novel Capsid Targeting the Central Nervous System (CNS), at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting— Presentations show that TfR1 CapX™ is being manufactured at clinical scale, a major hurdle in gene therapy development, and… Read more »
BioNJ Announces Lineup for BioPartnering ConferenceTRENTON, N.J., April 27, 2026 /PRNewswire/ — BioNJ is pleased to host its 16th Annual BioPartnering Conference on Tuesday, May… Read more »
AES Cleanroom Technology appoints John Groth as Chief Revenue OfficerMONTGOMERYVILLE, Pa., April 27, 2026 /PRNewswire/ — AES Cleanroom Technology, a leading provider of modular cleanroom design, manufacturing, and construction… Read more »
Zymo Research Launches Fecal Microbiome Discovery Grant to Enable the Next Breakthroughs in Human HealthIRVINE, Calif., April 27, 2026 /PRNewswire/ — Zymo Research Corp., a global leader in molecular tools for the life sciences,… Read more »
Avirmax Biopharma Inc. Proudly Presents at the 2026 ARVO Annual Meeting in Denver, ColoradoHAYWARD, Calif., April 27, 2026 /PRNewswire/ — Avirmax Inc. will deliver two scientific presentations at the 2026 Association for Research… Read more »
DELFI Diagnostics Appoints Charles Newton to Board of DirectorsVeteran biotech CFO and former healthcare investment banker joins the DELFI board as the company advances FirstLook Lung toward a… Read more »
Proteotype Diagnostics Selected for EU-Funded HER-CARE Doctoral Network, Signalling Growing Research Leadership in Precision OncologyCAMBRIDGE, England, April 27, 2026 /PRNewswire/ — Proteotype Diagnostics Ltd announced its selection as an industrial beneficiary in the HER-CARE… Read more »
Proteotype Diagnostics Selected for EU-Funded HER-CARE Doctoral Network, Signalling Growing Research Leadership in Precision OncologyCAMBRIDGE, England, April 27, 2026 /PRNewswire/ — Proteotype Diagnostics Ltd announced its selection as an industrial beneficiary in the HER-CARE… Read more »
QuantiPath Appoints Industry Veteran Roger Schaller to Board of DirectorsMolecular Diagnostics Executive with Proven Track Record of High-Profile Exits Joins QuantiPath’s Growing Leadership Team DENVER, April 27, 2026 /PRNewswire/… Read more »
Ferrotec Introduces Ferrobeads® DNA/RNA Isolation Kits for High-Efficiency Nucleic Acid ExtractionNew Ferrobeads offer Superior Binding Efficiency, Reliable Extraction and Open- Platform Flexibility LIVERMORE, Calif., April 27, 2026 /PRNewswire/ — Ferrotec… Read more »
Fathom Therapeutics, Formerly Atommap, Raises $47 Million in Oversubscribed Series A Financing to Translate Physics and AI-Enabled Small Molecule Design into Next-Generation MedicinesFinancing led by Sutter Hill Ventures; company names new Chief Business Officer, adds independent board member, and establishes Scientific Advisory… Read more »
Decoy Therapeutics to Present at Two Peptide Therapeutics Conferences in BostonCBO Peter Marschel to Lead HubXchange Roundtable on Computational Peptide Design CSO Dr. Barbara Hibner and CTO Dr. Michael Lipp… Read more »
BioMarin Completes Acquisition of Amicus TherapeuticsAcquisition Adds Galafold® (migalastat) for Fabry Disease and Pombiliti® (cipaglucosidase alfa-atga) + Opfolda® (miglustat) for Pompe Disease to BioMarin’s Commercial… Read more »
Nervonik Announces $52.5 Million Series B Financing to Advance Peripheral Nerve Stimulation TherapyLOS ANGELES, April 27, 2026 /PRNewswire/ — Nervonik, Inc., a clinical-stage medical device company developing next-generation peripheral nerve stimulation (PNS)… Read more »
FDA grants Priority Review for IMAAVY® (nipocalimab-aahu) as the potential first approved treatment for people living with warm autoimmune hemolytic anemia (wAIHA)Priority Review is granted to medicines that may offer significant improvements in safety or effectiveness for serious conditions like warm… Read more »
TransCode Therapeutics Appoints Dr. Anna Moore as Chair of Scientific Advisory Board; Announces Sponsored Research Agreement with Michigan State UniversityBOSTON, April 27, 2026 /PRNewswire/ — TransCode Therapeutics, Inc. (NASDAQ: RNAZ), a clinical stage company pioneering RNA and immuno-oncology therapeutics… Read more »
Avista Therapeutics Announces Presentations at Upcoming Medical MeetingsPITTSBURGH, April 27, 2026 /PRNewswire/ — Avista Therapeutics, a preclinical gene therapy company built on deep clinical, computational and gene… Read more »
Nuvation Bio Announces National Comprehensive Cancer Network® Adds Taletrectinib (IBTROZI®) as Recommended Option to Clinical Practice Guidelines in Oncology for Central Nervous System CancersGuidelines include the next-generation targeted therapy as a systemic option for patients with ROS1-positive non-small cell lung cancer with brain… Read more »